drugset / Trial / NCT00354276

VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia

NCT00354276 ↗

Phase 2 Unknown 85 enrolled Vion Pharmaceuticals
Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as VNP40101M and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving VNP40101M followed by cytarabine may kill more cancer cells. PURPOSE: This phase II trial is studying how well VNP40101M followed by cytarabine works in treating older patients with acute myeloid leukemia.

Timeline

Start
2006-05
Primary completion
2008-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Cytarabine Small molecule — Intravenous
Subject laromustine Other / unclassified — Intravenous

Indications